Clinical trial
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With…
NCT00325897 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00325897 |
|---|---|
| Title | Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease |
| Official title | Effect of Chronic Macrolide Administration on the Frequency and Severity of COPD Exacerbations |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Macrolide Antibiotic (Azithromycin), Placebo |
| Enrollment | 1,142 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | May 15, 2006 |
| Last update posted | Nov 18, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: